目的:探讨右美托咪定复合亚麻醉剂量艾司氯胺酮对老年经皮椎体成形术患者镇痛镇静效果的影响。方法:选取2020年2月—2022年2月萍乡市第二人民医院收治的102例老年经皮椎体成形术患者为研究对象,用随机数字表法分为常规组(n=51,舒芬太尼...目的:探讨右美托咪定复合亚麻醉剂量艾司氯胺酮对老年经皮椎体成形术患者镇痛镇静效果的影响。方法:选取2020年2月—2022年2月萍乡市第二人民医院收治的102例老年经皮椎体成形术患者为研究对象,用随机数字表法分为常规组(n=51,舒芬太尼+右美托咪定)、观察组(n=51,右美托咪定+亚麻醉剂量艾司氯胺酮)。比较两组血流动力学指标[心率、平均动脉压(MAP)、中心静脉压(CVP)]、术后疼痛情况、躁动发生情况及不良反应。结果:麻醉诱导时(T1)和术后2 min(T2)时观察组MAP、心率、CVP均低于常规组,差异均有统计学意义(P<0.05)。观察组躁动程度低于常规组,差异有统计学意义(P<0.05)。观察组术后9、18、36 h Prince-Henry评分均低于常规组,差异均有统计学意义(P<0.05)。两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:右美托咪定复合亚麻醉剂量艾司氯胺酮用于老年经皮椎体成形术可稳定术中血流动力学,有利于降低患者躁动发生风险,减轻术后疼痛,且安全性较好。展开更多
Diabetes mellitus is a common chronic disease.With the improvement of living standards,the prevalence of diabetes mellitus in China is increasing.There are now more people with diabetes in China(>100 million)than i...Diabetes mellitus is a common chronic disease.With the improvement of living standards,the prevalence of diabetes mellitus in China is increasing.There are now more people with diabetes in China(>100 million)than in any other country.About half of these people with diabetes need to undergo at least one procedure in their lifetime.Diabetic patients have a much higher probability of perioperative dysglycemia than the normal population,which has a great impact on their prognosis.In addition,non-diabetic patients may also have abnormal blood glucose levels due to various reasons during the perioperative period,which will also lead to a series of adverse consequences.This ar ticle reviews the perioperative blood glucose management of patients to provide a reference for improving their health status.展开更多
文摘目的:探讨右美托咪定复合亚麻醉剂量艾司氯胺酮对老年经皮椎体成形术患者镇痛镇静效果的影响。方法:选取2020年2月—2022年2月萍乡市第二人民医院收治的102例老年经皮椎体成形术患者为研究对象,用随机数字表法分为常规组(n=51,舒芬太尼+右美托咪定)、观察组(n=51,右美托咪定+亚麻醉剂量艾司氯胺酮)。比较两组血流动力学指标[心率、平均动脉压(MAP)、中心静脉压(CVP)]、术后疼痛情况、躁动发生情况及不良反应。结果:麻醉诱导时(T1)和术后2 min(T2)时观察组MAP、心率、CVP均低于常规组,差异均有统计学意义(P<0.05)。观察组躁动程度低于常规组,差异有统计学意义(P<0.05)。观察组术后9、18、36 h Prince-Henry评分均低于常规组,差异均有统计学意义(P<0.05)。两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:右美托咪定复合亚麻醉剂量艾司氯胺酮用于老年经皮椎体成形术可稳定术中血流动力学,有利于降低患者躁动发生风险,减轻术后疼痛,且安全性较好。
基金supported by Emerging Industry Leading Talent Project of Shanxi Province (No.2020587)。
文摘Diabetes mellitus is a common chronic disease.With the improvement of living standards,the prevalence of diabetes mellitus in China is increasing.There are now more people with diabetes in China(>100 million)than in any other country.About half of these people with diabetes need to undergo at least one procedure in their lifetime.Diabetic patients have a much higher probability of perioperative dysglycemia than the normal population,which has a great impact on their prognosis.In addition,non-diabetic patients may also have abnormal blood glucose levels due to various reasons during the perioperative period,which will also lead to a series of adverse consequences.This ar ticle reviews the perioperative blood glucose management of patients to provide a reference for improving their health status.
